| Metric | Value (₹ Cr) | Q1 FY26 | Q2 FY25 |
|---|---|---|---|
| Revenue | 205.99 | 6.7% | 10.6% |
| Total Income | 210.16 | 6.7% | 10.1% |
| Expenditure | 178.61 | 5.4% | 7.9% |
| PBT | 31.55 | 15.1% | 24.2% |
| Net Profit | 23.95 | 16.7% | 22.2% |
| OPM | 28.72% | 2.09pp | 32.90pp |
| NPM | 11.39% | 0.97pp | 1.13pp |
| EPS | 7.38 | 16.2% | 21.6% |
Krsnaa Diagnostics Ltd Announces Q2 Results with 3% YoY Revenue Growth and 12% Decline in Profit Before Tax
07 Nov 2025 · 7 Nov 2025, 06:22 pm
Summary
Krsnaa Diagnostics Ltd has announced its Q2 results with a 3% YoY revenue growth and a 12% decline in profit before tax. The announcement was made in compliance with Regulation 30 read with Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.
Key Highlights
- 1
Q2 Results announced by Krsnaa Diagnostics Ltd
- 2
3% YoY revenue growth
- 3
12% decline in profit before tax
- 4
Compliance with Regulation 30 and Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015
Management Comments
Yogesh Yewale
Based on our review conducted as stated in paragraph 3 above, nothing has come to our attention that causes us to believe that the accompanying Statement prepared in accordance with the recognition and measurement principles laid down in Ind AS 34 and other recognized accounting principles generally accepted in India has not disclosed the information required to be disclosed in terms of the Regulations, including the manner in which it is to be disclosed, or that it contains any material misstatement.
Informational and educational content only. Not investment advice.